Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Tracking monthly expenses reveals spending patterns and helps you control costs. Start today to build stronger financial habits and clarity.
26,700 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
AI is reshaping software earnings. This article dives into Jensen Huang's view, two stock ideas, and practical steps ...
A high-profile shift at Base has changed the project’s direction. Jesse Pollak is stepping back from app leadership t...
The memory market is showing persistent strength, and SK Hynix sits at the center of the narrative. This article expl...
A fresh look at AI investing shows the most dramatic gains might come from broad market value and international stock...
A dramatic streaming deal sparks a rally in Paramount Skydance and reshapes the media landscape. This guide breaks do...
Archer Aviation’s stock rally fizzled as the market shifted away from high-growth bets with unproven models. This art...
Oil markets are tight and geopolitics keep the pressure on. This guide weighs whether SHEL stock can weather the sque...
Herald Investment Management disclosed a new 202,000-share position in DigitalOcean Holdings (DOCN), valued at roughl...
Can bloom energy stock going to $200 actually happen? This guide breaks down the catalysts, risks, and practical stra...
PayPal is extending the reach of its USD-backed PYUSD stablecoin to 70 international markets. With PYUSD supply surpa...
Archer Aviation faces a critical cash burn challenge as it works toward FAA certification and commercial revenues. Th...